MCHX Marchex (MCHX) Insider Trading, Ownership & Congress Trades
Software & IT · Services-prepackaged software · CIK 0001224133
Activist 13D
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
10
13F, latest reported quarter
What the filings say about MCHX
Activist stakes (13D), 180 days
1 filing
Largest: 18.5% of the class
Marchex insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for MARCHEX INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 16 earlier Form 4 trades (code P or S) here by this insider (16 buys), the last on Mar 26, 2025.
- -4.3% median (+5.6% mean) 90-day return after 11 previous buys.
- The trade is 0.2% of the 1,424,813 shares held after it.
- No other insider bought within 30 days.
- 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider EDENBROOK LONG ONLY VALUE FUND, LP bought about $3.9K of MCHX on Mar 27, 2025; 10 funds added in the latest 13F quarter.Context
- 15 earlier Form 4 trades (code P or S) here by this insider (15 buys), the last on Mar 25, 2025.
- -6.6% median (+3.4% mean) 90-day return after 10 previous buys.
- The trade is 2.2% of the 1,422,497 shares held after it.
- No other insider bought within 30 days.
- 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider EDENBROOK LONG ONLY VALUE FUND, LP bought about $52.9K of MCHX on Mar 26, 2025; 10 funds added in the latest 13F quarter.Context
- 14 earlier Form 4 trades (code P or S) here by this insider (14 buys), the last on Nov 10, 2023.
- -9.0% median (+1.6% mean) 90-day return after 9 previous buys.
- The trade is 5.0% of the 1,391,535 shares held after it.
- No other insider bought within 30 days.
- 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider EDENBROOK LONG ONLY VALUE FUND, LP bought about $121.1K of MCHX on Mar 25, 2025; 10 funds added in the latest 13F quarter.Context
- 28 earlier Form 4 trades (code P or S) here by this insider (28 buys), the last on Nov 15, 2024.
- +20.5% median (+23.1% mean) 90-day return after 11 previous buys.
- The trade is 1.5% of the 336,761 shares held after it.
- No other insider bought within 30 days.
- 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Miller Edwin A bought about $8.6K of MCHX on Nov 18, 2024; 10 funds added in the latest 13F quarter.Context
- 27 earlier Form 4 trades (code P or S) here by this insider (27 buys), the last on Nov 14, 2024.
- +32.7% median (+23.6% mean) 90-day return after 10 previous buys.
- The trade is 0.2% of the 331,781 shares held after it.
- No other insider bought within 30 days.
- 10 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Miller Edwin A bought about $1.4K of MCHX on Nov 15, 2024; 10 funds added in the latest 13F quarter.85 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
10 funds bought in last quarter
below 84% of Software & IT
Revenue
-5.6% year over year
below 79% of Software & IT
Margin
-11.5% net margin
below 61% of Software & IT
Buybacks
no share repurchases reported
Short interest
0.2% of the float short (float per yahoo 2026-10-26) · 1.0 days to cover · settled 2026-09-30
The situation: each line is one rule over one dataset
Russell C. Horowitz disclosed a 5%+ stake (18.5%) in the last six months.
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch MCHX
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-30.0%12M
13D/G stake
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns MCHX: institutional holders (13F)
13F holdings, latest reported quarter
14,664,380 sh
$23.6M
1,576,464 sh
$2.5M
1,300,388 sh
$2.2M
1,079,881 sh
$1.7M
800,000 sh
$1.3M
Congress trades in MCHX
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
13D: intends to influence · 13G: passive
Russell C. Horowitz
Activist 13D · 2026-07-07
18.5%
MCHX planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
MCHX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Philotimo Focused Growth & Income
$2.1M position · as of 2026-06-30
1.5%
Ultra-Small Company Market Fund
$64.4K position · as of 2026-06-30
0.0%
iShares Micro-Cap ETF
$117.6K position · as of 2026-06-30
0.0%
1290 VT Micro Cap Portfolio
$6.3K position · as of 2026-06-30
0.0%
LVIP Dimensional U.S. Core Equity 2 Fund
$8.6K position · as of 2026-06-30
0.0%
Fidelity Extended Market Index Fund
$310.8K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows 10 funds added last quarter. Each figure is a federal filing, dated the day it went public.
MCHX financials
Revenue growth
-5.6%
XBRL, annual
Net margin
-11.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$44.0M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MCHX
| FY Dec 2025 | $45.4M |
| FY Dec 2024 | $48.1M |
| FY Dec 2023 | $49.9M |
| FY Dec 2022 | $52.2M |
| FY Dec 2021 | $53.5M |
| Jun 2026 | $11.0M |
| Mar 2026 | $10.6M |
| Dec 2025 | $10.8M |
| Sep 2025 | $11.5M |
| Jun 2025 | $11.7M |
| Mar 2025 | $11.4M |
| Dec 2024 | $11.9M |
| Sep 2024 | $12.6M |
At each fiscal year end
Single quarter
Net margin, TTM
-12.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MCHX
| FY Dec 2025 | -11.5% |
| FY Dec 2024 | -10.3% |
| FY Dec 2023 | -19.9% |
| FY Dec 2022 | -15.8% |
| FY Dec 2021 | -8.2% |
| Jun 2026 | -3.7% |
| Mar 2026 | -16.2% |
| Dec 2025 | -21.4% |
| Sep 2025 | -8.9% |
| Jun 2025 | +0.7% |
| Mar 2025 | -17.4% |
| Dec 2024 | -16.0% |
| Sep 2024 | -6.6% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM MCHX
| FY Dec 2025 | n/a |
| FY Dec 2024 | -$1.5M |
| FY Dec 2023 | -$5.8M |
| FY Dec 2022 | -$5.2M |
| FY Dec 2021 | -$7.7M |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | $116.0K |
| Sep 2025 | $290.0K |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | $757.0K |
| Sep 2024 | $199.0K |
At each fiscal year end
Single quarter
Debt to equity
0.03x
current debt only, 2023-12-31 (30 months older than the period end); equity 2026-06-30
Debt to equity MCHX
| FY Dec 2025 | 0.03x |
| FY Dec 2024 | 0.02x |
| FY Dec 2023 | 0.02x |
| FY Dec 2022 | 0.12x |
| FY Dec 2021 | 0.10x |
| Jun 2026 | 0.03x |
| Mar 2026 | 0.03x |
| Dec 2025 | 0.03x |
| Sep 2025 | 0.03x |
| Jun 2025 | 0.02x |
| Mar 2025 | 0.03x |
| Dec 2024 | 0.02x |
| Sep 2024 | 0.02x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.94x
TTM operating cash flow over current debt only, 2023-12-31 (30 months older than the period end)
Cash flow to debt MCHX
| FY Dec 2025 | -1.76x |
| FY Dec 2024 | -1.38x |
| FY Dec 2023 | -5.49x |
| FY Dec 2022 | -0.45x |
| FY Dec 2021 | -1.23x |
| Jun 2026 | -0.94x |
| Mar 2026 | 0.88x |
| Dec 2025 | -1.76x |
| Sep 2025 | -0.82x |
| Jun 2025 | -0.70x |
| Mar 2025 | -1.56x |
| Dec 2024 | -1.38x |
| Sep 2024 | -0.28x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-17.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MCHX
| FY Dec 2025 | -16.7% |
| FY Dec 2024 | -14.4% |
| FY Dec 2023 | -24.8% |
| FY Dec 2022 | -17.2% |
| FY Dec 2021 | -8.4% |
| Jun 2026 | -17.9% |
| Mar 2026 | -16.5% |
| Dec 2025 | -16.7% |
| Sep 2025 | -14.6% |
| Jun 2025 | -13.9% |
| Mar 2025 | -16.5% |
| Dec 2024 | -14.4% |
| Sep 2024 | -11.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-13.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MCHX
| FY Dec 2025 | -12.6% |
| FY Dec 2024 | -10.9% |
| FY Dec 2023 | -19.0% |
| FY Dec 2022 | -13.4% |
| FY Dec 2021 | -6.2% |
| Jun 2026 | -13.7% |
| Mar 2026 | -12.6% |
| Dec 2025 | -12.6% |
| Sep 2025 | -11.3% |
| Jun 2025 | -10.6% |
| Mar 2025 | -12.7% |
| Dec 2024 | -10.9% |
| Sep 2024 | -9.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital MCHX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-15.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed MCHX
| FY Dec 2025 | -17.5% |
| FY Dec 2024 | -12.4% |
| FY Dec 2023 | -23.4% |
| FY Dec 2022 | -16.7% |
| FY Dec 2021 | -21.6% |
| Jun 2026 | -15.9% |
| Mar 2026 | -16.5% |
| Dec 2025 | -17.5% |
| Sep 2025 | -14.4% |
| Jun 2025 | -13.9% |
| Mar 2025 | -14.5% |
| Dec 2024 | -12.4% |
| Sep 2024 | -10.7% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing MCHX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value MCHX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield MCHX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing MCHX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $45.4M | $48.1M | $49.9M | $52.2M |
| Operating income | -$5.7M | -$4.4M | -$9.6M | -$8.1M |
| Net income | -$5.2M | -$4.9M | -$9.9M | -$8.2M |
| EPS (diluted) | -0.12 | -0.11 | -0.23 | -0.19 |
| Operating cash flow | -$1.4M | -$1.1M | -$4.4M | -$2.3M |
| Cash | $9.9M | $12.8M | $14.6M | $20.5M |
SEC XBRL, fiscal years, as known on 2026-10-28
MCHX Stock Sonar score 5/7 axes
Find similar shapesCompareMCHX ranks highest on risk and compliance (86th percentile) and financial health (47th), and lowest on institutional and government (16th), among Software & IT peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MCHX filings, in plain words
Read the full summary
1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 18.5% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
